Natural Alternatives International, Inc. (NAII) Financial Statements (2024 and earlier)

Company Profile

Business Address 1535 FARADAY AVENUE
CARLSBAD, CA 92008-7319
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q1
6/30/2023
Q4
3/31/2023
Q3
12/31/2022
Q2
9/30/2022
Q1
6/30/2022
Q4
3/31/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 15,56012,77312,34121,83318,575
Cash and cash equivalents 15,56012,77312,34121,83318,575
Receivables 8,24810,28115,26717,48916,736
Inventory, net of allowances, customer advances and progress billings 39,30936,03639,99032,47536,800
Inventory 39,30936,03639,99032,47536,800
Derivative instruments and hedges, assets 9111,7454,4413,1442,445
Other undisclosed current assets 2,2582,2162,3651,8053,650
Total current assets: 66,28663,05174,40476,74678,206
Noncurrent Assets
Operating lease, right-of-use asset 19,95820,54921,13621,70114,049
Property, plant and equipment 54,75754,16951,38444,57340,400
Deferred income tax assets      
Other noncurrent assets 2,9262,8092,6442,9832,833
Total noncurrent assets: 77,64177,52775,16469,25757,282
TOTAL ASSETS: 143,927140,578149,568146,003135,488
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 12,60815,56622,90422,81923,696
Taxes payable335174513
Employee-related liabilities2,5553,6733,110
Accounts payable 10,89013,17917,65916,18517,838
Accrued liabilities 1,7182,3872,3552,7872,235
Deferred revenue 326425108140372
Debt 9,4093073,705302300
Derivative instruments and hedges, liabilities   67  
Other undisclosed current liabilities 3,2252,250   
Total current liabilities: 25,56818,54826,78423,26124,368
Noncurrent Liabilities
Long-term debt and lease obligation 9,2779,35030,56631,54024,148
Long-term debt, excluding current maturities 9,2779,3509,4229,4939,563
Liabilities, other than long-term debt 22,47623,1502,3622,6821,895
Accounts payable and accrued liabilities 9879879871,1181,118
Deferred income tax liabilities  2844841,0061,220360
Liability, pension and other postretirement and postemployment benefits 419394369344417
Operating lease, liability 20,78621,28521,14422,04714,585
Total noncurrent liabilities: 31,75332,50032,92834,22226,043
Total liabilities: 57,32151,04859,71257,48350,411
Equity
Equity, attributable to parent 86,60689,53089,85688,52085,077
Common stock 9189898989
Treasury stock, value (22,855)(22,411)(21,849)(21,352)(20,954)
Additional paid in capital 31,14630,89030,65830,42330,188
Accumulated other comprehensive income 784352,2441,6991,198
Retained earnings 78,14680,52778,71477,66174,556
Total equity: 86,60689,53089,85688,52085,077
TOTAL LIABILITIES AND EQUITY: 143,927140,578149,568146,003135,488

Income Statement (P&L) ($ in thousands)

9/30/2023
Q1
6/30/2023
Q4
3/31/2023
Q3
12/31/2022
Q2
9/30/2022
Q1
6/30/2022
Q4
3/31/2022
Q3
Revenues 32,69942,29543,12752,52642,373
Cost of revenue
(Cost of Goods and Services Sold)
  (36,081)(37,756)(44,237)(34,980)
Gross profit: 32,6996,2145,3718,2897,393
Operating expenses (107)(3,729)(3,829)(4,513)(4,119)
Other undisclosed operating loss  (35,080)    
Operating income (loss): (2,488)2,4851,5423,7763,274
Nonoperating income (expense)  (199)(224)103(88)
Gain (loss), foreign currency transaction, before tax  (143)(147)153(40)
Other nonoperating income (expense)  (10)(6)(12)(29)
Income (loss) from continuing operations before income taxes: (2,488)2,2861,3183,8793,186
Income tax expense (benefit)  (473)(265)(774)(682)
Income (loss) from continuing operations: (2,488)1,8131,0533,1052,504
Income before gain (loss) on sale of properties:1,0533,1052,504
Net income (loss): (2,488)1,8131,0533,1052,504
Other undisclosed net income attributable to parent  107    
Net income (loss) available to common stockholders, diluted: (2,381)1,8131,0533,1052,504

Comprehensive Income ($ in thousands)

9/30/2023
Q1
6/30/2023
Q4
3/31/2023
Q3
12/31/2022
Q2
9/30/2022
Q1
6/30/2022
Q4
3/31/2022
Q3
Net income (loss): (2,488)1,8131,0533,1052,504
Other undisclosed comprehensive income     130 
Comprehensive income (loss): (2,488)1,8131,0533,2352,504
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (1,809)545371474
Comprehensive income (loss), net of tax, attributable to parent: (2,488)41,5983,6062,978

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: